Ophthalmology Times Europe Staff

Real-world data support EndoArt as donor-independent option in high-risk patients

Biologic therapies linked to high remission rates over 2-year follow-up

Researchers identify microbial shifts tied to corneal disease history

Deeper anterior chamber depth and shorter disease course predicted better surgical outcomes

The US FDA approves Lumvoa for TED in active or chronic stages, showing rapid proptosis and diplopia improvements; safety monitoring includes hearing, hyperglycemia and infusion reactions.

Real-world data show dexamethasone intravitreal implant improves vision and thickness in RVO macular edema, with earlier anti-VEGF switching yielding better gains.

A sutureless amniotic membrane matrix achieved faster healing and lower costs than standard PED care in a two-centre NHS audit.

A retrospective study of 114 oculoplastic surgery patients found trehalose added to sodium hyaluronate improved tear break-up time, corneal staining, and meibomian gland loss compared with sodium hyaluronate alone, particularly after eyelid reconstruction.